Tumour-first DNA testing as a gateway to germline screening in patients with metastatic prostate cancer
European Journal of Cancer · 2026-11 · 248 · 117060
DOI: 10.1016/j.ejca.2026.117060 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Iris S H Kloots und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Germ-Line Mutation, Genetic Testing, Biomarkers, Tumor. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Radboud Universitair Medisch Centrum.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of Urology, Radboud University Medical Centre, the Netherlands.
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands. Electronic address: niven.mehra@radboudumc.nl.
Förderung
- Radboud Universitair Medisch Centrum
Zitieren
APA
Kloots, I. S. H., Kets, C. M., Schuurs-Hoeijmakers, J., Kroeze, L. I., Pillay, S., van Oort, I. M., Bloemendal, H. J., Gerritsen, W. R., Ligtenberg, M. J. L., & Mehra, N. (2026). Tumour-first DNA testing as a gateway to germline screening in patients with metastatic prostate cancer. European Journal of Cancer, 248, 117060. https://doi.org/10.1016/j.ejca.2026.117060
Vancouver
Kloots ISH, Kets CM, Schuurs-Hoeijmakers J, Kroeze LI, Pillay S, van Oort IM, et al. Tumour-first DNA testing as a gateway to germline screening in patients with metastatic prostate cancer. European Journal of Cancer. 2026;248:117060. doi:10.1016/j.ejca.2026.117060
BibTeX
@article{Kloots2026,
author = {Kloots, Iris S H and Kets, C Marleen and Schuurs-Hoeijmakers, Janneke and Kroeze, Leonie I and Pillay, Stephanie and van Oort, Inge M and Bloemendal, Haiko J and Gerritsen, Winald R and Ligtenberg, Marjolijn J L and Mehra, Niven},
title = {Tumour-first DNA testing as a gateway to germline screening in patients with metastatic prostate cancer},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117060},
doi = {10.1016/j.ejca.2026.117060}
}
EUVIMED